CXCL13 as biomarker for histological involvement in Sjögren’s syndrome
Lara D. Veeken2019Vol. 59(1), pp. 165–170
Citations Over TimeTop 10% of 2019 papers
Serena Colafrancesco, Roberta Priori, Charlotte G. Smith, Antonina Minniti, Valentina Iannizzotto, Elena Pipi, Davide Lucchesi, Elena Pontarini, Saba Nayar, Joana Campos, Francesca Arienzo, Massimo Fusconi, Bruna Cerbelli, Carla Giordano, Guido Valesini, Stefano Bombardieri, Benjamin A. Fisher, Francesca Barone
Abstract
Our data foster the use of CXCL13 to monitor the extent of local pathology in SS and its validation in longitudinal clinical studies.
Related Papers
- → CXCL13 is a plasma biomarker of germinal center activity(2016)351 cited
- → Ectopic Germinal Center Formation in Rheumatoid Synovitis(2003)232 cited
- → The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis(2006)167 cited
- → Immune metabolism regulation of the germinal center response(2020)42 cited
- → CXCL13 (BCA‐1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells(2002)74 cited